Contemporary Heart Transplantation

Linda Bogar earned her medical degree and completed her surgical and cardiothoracic transplant fellowships at Temple University in Philadelphia, PA. She later finished a cardiothoracic surgery residency at Thomas Jefferson University Hospital in Philadelphia, PA. Dr. Bogar has served on both regional and national committees for OPTN/UNOS and has published numerous publications.Dr. Bogar brings 15 years of clinical and surgical experience besides expertise in complex and highrisk cardiac surgery along with a focus in heart and lung transplant and mechanical circulatory support. Dr. Bogar is currently practicing at AdventHealth Orlando as a cardiothoracic transplant surgeon. Her focus remains on heart and lung transplant, mechanical circulatory assist devices, and ECMO, along with high-risk coronary bypass surgery.
Dr. Bogar is a current and active member of the Society of Thoracic Surgeons, the International Society of Heart and Lung Transplantation, and the American College of Cardiology.

April Stempien-Otero graduated from Dartmouth College and attended medical school at the University of Connecticut School of Medicine. She completed residency in Internal Medicine at the University of Virginia where she was selected as Chief Resident. She then attended cardiology fellowship at the University of Washington School of Medicine, completing as Chief Fellow and obtaining specialized clinical training in Advanced Heart Failure and Cardiac Transplantation. There she completed research fellowships in inflammation and myocardial biology prior to being appointed as faculty.
She is currently the Craig Tall Family Chair in Heart Failure Research and an Associate Professor of Medicine and Adjunct Associate Professor of Pathology at the University of Washington. As a physician-scientist, she conducts novel research in the mechanisms of advanced heart failure in subjects undergoing left ventricular assist implantation. These include studies of stem cell injections and novel pharmaceuticals to reverse inflammation and fibrosis.
Dr. Stempien-Otero has been listed as Best Doctor in America for over a decade and has been appointed to major committees of the American Heart Association and United Network for Organ Sharing.

Section 1: Historical Background
History of Heart Transplant
Immunosuppression related to transplant
Section 2: Pre-operative evaluation process
Pathophysiology of heart failure
Contraindications to heart transplantation
Psycho-Social considerations
Multi-disciplinary team input
Section 3: Organ Allocation
Current Listing System
Proposed Changes
Matching donor to recipient
Section 4: Organ Procurement
Organ preservation
The donor operation
Ex Vivo perfusion
Section 5: Transplant Operation
Surgical techniques
Surgical Complications
Section 6: Anesthesia Management
Anesthesia techniques for heart transplant
Section 7: Post-operative ICU and hospital management
Ventilator management
Weaning of inotropes
Imaging studies and laboratory testing
Physical and Occupational therapy
Section 8: Transplant Immunology
Induction and maintenance agents
Complication of immunosuppression
Rejection
Section9: Long term outpatient management of the heart transplant patient
Chronic immunosuppression medications
Infection prophylaxis
Monitoring for rejection
Section 10: Mechanical Support of the pre-transplant patient
ECMO
LVAD support
Section 11: The Contemporary successful Heart transplant program
Regulatory agencies
Quality measures
The financial aspect of the heart transplant program
The multi-disciplinary approach
Administrative support of the program
Section 12: Special Topics
Re-transplantation
Combined Heart transplant with other organ transplantation
Section 13,Outcomes Data
Survival data
Quality of life
Chronic rejection
Malignancy after transplant
Section 14: The future of heart transplantation
Advances in immunosuppression
Stem cell therapy
DCD donor use
Will we still be doing heart transplants in 10 years.